Senate Democrats this month prepared their first attempt to salvage one of the most popular elements of President Joe Biden’s stalled “Build Back Better” plan — a proposal to cap insulin costs to $35 a month.
May not go well.
It’s true, even the idea of helping Millions of Americans have diabetes Can’t afford key drugs there are huge public support and even bipartisan followers. But, there’s also politics — between Democrats and Republicans, of course, but also between Democrats.
Sen. Raphael Warnock (D-Ga.) is sponsoring a bill expected to be introduced in March or early April that would cap prices. But the bill pursuing Warnock would remove the clause from the Build Back Better Act.
According to a recent report, drug companies have dramatically inflated U.S. prices, making Americans pay more than 10 times what other developed nations do Detailed investigation by the federal government.
Senate Majority Leader Chuck Schumer emphasized the obvious selling point of lowering the cost of insulin when he announced the issue would be a priority ahead of Congress’ Presidents Day break. “It’s ridiculous, it’s ridiculous that people with diabetes are sometimes paying more than $600 for a 40-day supply of insulin,” Schumer said.
“Our caucus has a lot of interest in pursuing this proposal, so it will be a priority for Democrats in the coming weeks,” he said, inviting Republicans to get involved. “This has long been a bipartisan issue: as many as 20 states across the country—many of which have Republican legislatures and governors—have passed state insulin caps. There’s no reason it shouldn’t be in this agency It’s bipartisan.”
Still, complications start with Democrats, even if they seem entirely surmountable.
The first is that Biden and many of the more progressive Democrats in Congress still want to pass a stripped-down “build back better” plan. They want to try again to create a welcome package of tax, climate and health provisions that could be endorsed by West Virginia Senator Joe Manchin, a conservative Democrat who blocked More ambitious bills. Democrats can speed up passage of the new version by 51 votes through Congress under the fast-track budget adjustment rules they’ve already passed.
Just last month, just days before Schumer announced Warnock’s insulin plan, Biden was talking about “building back better” and limiting insulin costs, referring to insulin again in his State of the Union address, saying It’s Shannon Davis and her 13-year-old son, Joshua, who has type 1 diabetes like his father.
“Imagine what it’s like to watch your child need insulin and not know how you’re going to pay for it. What effect does it have on your dignity,” Biden said, reiterating that he limited insulin to $35 a month plan.
Pulling the insulin measure from Build Back Better removes this powerful talking point, meaning the insulin-only bill needs 60 votes to pass the Senate, not a simple majority.
The president made no mention of his larger spending plan in his March 1 speech. Schumer’s acceptance of the Warnock Act shows Democrats see the value of Warnock taking the lead on a popular issue as he faces a difficult re-election campaign in Georgia this year.
“I’m a pastor; I’m on the field, so I know everyone knows someone with diabetes,” Warnock said in the video In it, he states that 12 percent of Georgians suffer from the disease. “I’ve seen firsthand the effects of diabetes on Georgians.”
Senators have been working with Schumer and the chairmen of the finance and health committees on how best to move forward with the measure, according to background information provided by Warnock’s office. He has also been working with Biden’s Centers for Medicare and Medicaid Services on technical details, suggesting at least tacit support from the White House.
The Hill Democratic staffer was candid about the prospect of Build Back Better, describing it as less of a race car just entering the pits than an old car on cinder blocks. Some senators declared, does not exist .
Other Democratic staffers said it could be useful to pull prescription reform out of the “build back better” package. Items included in the settlement process should directly affect the federal budget. Insulin provisions have greater financial implications for insurers and drugmakers than the federal government, making them face a Republican congressional challenge.
By starting a salvage operation with a popular piece, and attracting enough Republicans to succeed, Democrats can use insulin caps as a model for gaining a minority other blocks Rebuild better through Congress.
However, there is no clear signal that Republican senators will cooperate, although about 20 of them have previously expressed support for measures to control insulin prices. Warnock’s staff said the senator has received positive feedback on the proposal from his Democratic and Republican colleagues.
Several key Republicans, including Minority Leader Mitch McConnell and Sen. Susan Collins of Maine, co-chair of the Senate Diabetes Caucus, did not respond when asked about Warnock’s bill.
Jess Andrews, a spokesman for Sen. John F. Kennedy (R-La.), introduced three bills to lower the cost of insulin, one just in September This includes the cap, saying the politician has nothing to say at this time.
Sen. Chuck Grassley (R-Iowa), who has worked extensively with Finance Committee Chairman Ron Wyden (Oregon) on the insulin cost investigation and legislation, has no comment on Warnock’s bill.
A spokesperson did note that Grassley prefers a broader approach. “There is no question that insulin is one of many essential medicines that is becoming increasingly unaffordable,” said Grassley spokesman Taylor Foy. “Bipartisan proposals in Congress, such as the Grassley-Wyden Prescription Drug Price Reduction Act, would address not only the root cause of rising insulin prices, but many other drugs.”
Virtually every advocacy group dedicated to a specific disease wants Congress to control the price of essential medicines to treat or cure that disease. But so far, Congress lacks the will or the means to address the problem in this way.
McConnell Undermining Grassley’s broader bill In 2019, Republicans held a majority in the Senate. But now Schumer controls which bills can be voted on.
The bill could pass this time if 10 of Republicans who want to rein in insulin costs are willing to ally with weak Democrats who face stiff competition. If they aren’t, Democrats will get a consolation prize, highlighting how Republicans are blocking popular reforms that millions demand.
KHN (Kaiser Health News) is a national newsroom that provides in-depth news coverage on health issues.Along with policy analysis and polling, KHN is one of the top three operating programs in the U.S. KFC (Kaiser Family Foundation). KFF is a donating non-profit organization that provides information on health issues to the state.
